Ma Kuang Healthcare Holding LimitedTPEX: 4139

Announcement that subsidiary MKS acquisition of houses and buildings

· Issued by Ma Kuang Healthcare Holding Limited
Close
Today's Information

Provided by: MA KUANG HEALTHCARE HOLDING LIMITED
SEQ_NO 1 Date of announcement 2022/08/04 Time of announcement 20:01:51
Subject
 Announcement that subsidiary MKS acquisition of
houses and buildings
Date of events 2022/08/04 To which item it meets paragraph 20
Statement
1.Name and nature of the underlying asset (e.g., land
located at Sublot XX, Lot XX, North District, Taichung City):
Block 185 Toa Payoh Central #01-336 Singapore 310185
2.Date of the occurrence of the event:2022/08/04
3.Transaction unit amount (e.g.XX square meters, equivalent
to XX ping), unit price, and total transaction price:
 Transaction amount:SGD 3,900 thousands
                  (NTD 83,473 thousands)
Total area:115.3 sq m (34.785 ping)
unit price:SGD 33,913 dollars/sq m
           (NTD 725,851  dollars/sq m)
           SGD 112,117 dollars/ping
           (NTD 2,399,674 dollars/sq m)
4.Trading counterparty and its relationship to the
Company (if the trading counterparty is a natural
person and furthermore is not a related party of the
 Company, the name of the trading counterparty is
not required to be disclosed):
Trading counterparty:JUI WEI INVESTMENTS PTE LTD.(JW)
its relationship to the Company: JW's director and MKS's
    one of directors are the same person.
5.Where the trading counterparty is a related party,
announcement shall also be made of the reason for
choosing the related party as trading counterparty and
the identity of the previous owner, its relationship with
 the Company and the trading counterparty, and the
previous date and monetary value of transfer:
(1)the reason for choosing the related party:
Based on business planning and management considerations
(2)the identity of the previous owner:
MA KUANG CHINESE MEDICINE AND RESEARCH CENTRE PTE. LTD.
(3)its relationship with the Company:
The Company
(4)the previous date and monetary value of transfer:
March,2014 and SGD 3,500 thousand(NTD 74,912thousand)
6.Where an owner of the underlying assets within the past
 five years has been a related party of the Company, the
announcement shall also include the date and price of
acquisition and disposal by the related party, and its
 relationship to the Company at the time of the
transaction:
NA
7.Projected gain (or loss) through disposal (not
applicable for acquisition of assets; those with deferral
should provide a table explaining recognition):
NA
8.Terms of delivery or payment (including payment period
and monetary value), restrictive covenants in the contract,
 and other important terms and conditions:
(1)Terms of delivery or payment:
In accordance with regulations of the contract
(2)restrictive covenants in the contract:NA
(3)other important terms and conditions:NA
9.The manner of deciding on this transaction (such as
 invitation to tender, price comparison, or price
negotiation), the reference basis for the decision
on price, and the decision-making department:
Decision making process and pricing:
  The price was decided by mutual consent and expert
  evaluation report
Decision-making unit: Board of Directors
10.Name of the professional appraisal firm or company
and its appraisal price:
(1)Name of the professional appraisal firm or company:
 UNITED VALUERS PTE. LTD.
(2)its appraisal price:
  SGD 4,000 thousand (NTD 85,613 thousand)
11.Name of the professional appraiser:
Teo Beng Hock
12.Practice certificate number of the professional
appraiser:
AD041-2009516J
13.The appraisal report has a limited price, specific
price, or special price:
None
14.An appraisal report has not yet been obtained:None
15.Reason for an appraisal report not being obtained:None
16.Reason for any significant discrepancy with the appraisal
reports and opinion of the CPA:NA
17.Name of the CPA firm:NA
18.Name of the CPA:NA
19.Practice certificate number of the CPA:NA
20.Broker and broker's fee:NA
21.Concrete purpose or use of the acquisition or disposal:
Activate assets
22.Any dissenting opinions of directors to the present
transaction:NA
23.Whether the counterparty of the current transaction
 is a related party:Yes
24.Date of the board of directors' resolution:
2022/08/04
25.Date of ratification by supervisors or approval
by the audit committee:
2022/08/04
26.The transaction is to acquire a real property or
right-of-use asset from a related party:
None
27.The price assessed in accordance with the Article
16 of the Regulations Governing the Acquisition and
Disposal of Assets by Public Companies:NA
28.Where the above assessed price is lower than the
transaction price, the price assessed in accordance
with the Article 17 of the same regulations:NA
29.Any other matters that need to be specified:
The Singapore exchange rate is 21.4033

Company analysis

Earlier from Ma Kuang Healthcare

All Ma Kuang Healthcare news releases